Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Gordon A Begg"'
Autor:
Gordon A Begg, James O'Neill, Afzal Sohaib, Ailsa McLean, Chris B Pepper, Lee N Graham, Andrew J Hogarth, Stephen P Page, Richard G Gillott, Nicola Hill, Jacqueline Walshaw, Richard J Schilling, Prapa Kanagaratnam, Muzahir H Tayebjee
Publikováno v:
PLoS ONE, Vol 14, Iss 4, p e0212903 (2019)
IntroductionElectrical coupling index (ECI) and contact force (CF) have been developed to aid lesion formation during catheter ablation. ECI measures tissue impedance and capacitance whilst CF measures direct contact. The aim was to determine whether
Externí odkaz:
https://doaj.org/article/c85125532b8e470cbb6bdc2f0b7abb42
Autor:
Gordon A Begg, Rashed Karim, Tobias Oesterlein, Lee N Graham, Andrew J Hogarth, Stephen P Page, Christopher B Pepper, Kawal Rhode, Gregory Y H Lip, Arun V Holden, Sven Plein, Muzahir H Tayebjee
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0189936 (2018)
To test the ability of four circulating biomarkers of fibrosis, and of low left atrial voltage, to predict recurrence of atrial fibrillation after catheter ablation.Circulating biomarkers potentially may be used to improve patient selection for atria
Externí odkaz:
https://doaj.org/article/26dc84da9222458c86954a53363d8093
Autor:
Gordon A. Begg, John P Greenwood, Arun V. Holden, Muzahir H. Tayebjee, Rashed Karim, Gregory Y.H. Lip, Peter P Swoboda, Sven Plein, Tobias Oesterlein, Eduard Shantsila, Kawal Rhode
Publikováno v:
Begg, G A, Swoboda, P P, Karim, R, Oesterlein, T, Rhode, K, Holden, A V, Greenwood, J P, Shantsila, E, Lip, G Y H, Plein, S & Tayebjee, M H 2020, ' Imaging, biomarker and invasive assessment of diffuse left ventricular myocardial fibrosis in atrial fibrillation ', Journal of Cardiovascular Magnetic Resonance, vol. 22, no. 1, 13 . https://doi.org/10.1186/s12968-020-0603-y
Journal of Cardiovascular Magnetic Resonance, Vol 22, Iss 1, Pp 1-7 (2020)
Journal of cardiovascular magnetic resonance, 22 (1), Art. Nr.: 13
Journal of Cardiovascular Magnetic Resonance
Journal of Cardiovascular Magnetic Resonance, Vol 22, Iss 1, Pp 1-7 (2020)
Journal of cardiovascular magnetic resonance, 22 (1), Art. Nr.: 13
Journal of Cardiovascular Magnetic Resonance
Background Using cardiovascular magnetic resonance imaging (CMR), it is possible to detect diffuse fibrosis of the left ventricle (LV) in patients with atrial fibrillation (AF), which may be independently associated with recurrence of AF after ablati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd4d67099c75407921c3e0f7e160360e
Publikováno v:
International Journal of Cardiology. 220:155-161
Rhythm control of atrial fibrillation (AF) remains challenging, with modest long-term success rates. Atrial fibrosis has been associated with AF, but the clinical utility of assessment of this fibrosis has yet to be fully elucidated. In this paper we
Autor:
Christopher B. Pepper, Stephen P. Page, Richard Gillott, Lee N. Graham, Muzahir H. Tayebjee, Richard J. Schilling, Gordon A. Begg, Nicola J. Hill, Jacqueline Walshaw, Andrew J. Hogarth, Afzal Sohaib, Ailsa McLean, James O’Neill, Prapa Kanagaratnam
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 4, p e0212903 (2019)
PLoS ONE, Vol 14, Iss 4, p e0212903 (2019)
IntroductionElectrical coupling index (ECI) and contact force (CF) have been developed to aid lesion formation during catheter ablation. ECI measures tissue impedance and capacitance whilst CF measures direct contact. The aim was to determine whether
Autor:
Kawal Rhode, Gregory Y.H. Lip, Rashed Karim, Andrew J. Hogarth, Chris Pepper, Lee N. Graham, Tobias Oesterlein, Arun V. Holden, Stephen P. Page, Gordon A. Begg, Sven Plein, Muzahir H. Tayebjee
Publikováno v:
Begg, G A, Karim, R, Oesterlein, T, Graham, L N, Hogarth, A J, Page, S P, Pepper, C B, Rhode, K, Lip, G Y H, Holden, A V, Plein, S & Tayebjee, M H 2018, ' Left atrial voltage, circulating biomarkers of fibrosis, and atrial fibrillation ablation. A prospective cohort study ', PLoS ONE, vol. 13, no. 1, e0189936 . https://doi.org/10.1371/journal.pone.0189936
Begg, G A, Karim, R, Oesterlein, T, Graham, L N, Hogarth, A J, Page, S P, Pepper, C B, Rhode, K, Lip, G Y H, Holden, A V, Plein, S & Tayebjee, M H 2018, ' Left atrial voltage, circulating biomarkers of fibrosis, and atrial fibrillation ablation. A prospective cohort study ', PLOS ONE, vol. 13, no. 1, e0189936 . https://doi.org/10.1371/journal.pone.0189936
PLoS one, 13 (1), Art.Nr. e0189936
PLoS ONE
PLoS ONE, Vol 13, Iss 1, p e0189936 (2018)
Begg, G A, Karim, R, Oesterlein, T, Graham, L N, Hogarth, A J, Page, S P, Pepper, C B, Rhode, K, Lip, G Y H, Holden, A V, Plein, S & Tayebjee, M H 2018, ' Left atrial voltage, circulating biomarkers of fibrosis, and atrial fibrillation ablation. A prospective cohort study ', PLOS ONE, vol. 13, no. 1, e0189936 . https://doi.org/10.1371/journal.pone.0189936
PLoS one, 13 (1), Art.Nr. e0189936
PLoS ONE
PLoS ONE, Vol 13, Iss 1, p e0189936 (2018)
AIMS: To test the ability of four circulating biomarkers of fibrosis, and of low left atrial voltage, to predict recurrence of atrial fibrillation after catheter ablation.BACKGROUND: Circulating biomarkers potentially may be used to improve patient s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dae9832f8ba85bf2930e15041f7c044
https://kclpure.kcl.ac.uk/ws/files/86252094/Left_atrial_voltage_circulating_BEGG_Published2January2018_GOLD_VoR_CC_BY_.pdf
https://kclpure.kcl.ac.uk/ws/files/86252094/Left_atrial_voltage_circulating_BEGG_Published2January2018_GOLD_VoR_CC_BY_.pdf
Autor:
Rashed Karim, Stephen P. Page, Sven Plein, Muzahir H. Tayebjee, Gregory Y.H. Lip, Andrew J. Hogarth, Chris Pepper, Tobias Oesterlein, Kawal Rhode, Lee N. Graham, Arun V. Holden, Gordon A. Begg
Publikováno v:
Begg, G A, Karim, R, Oesterlein, T, Graham, L N, Hogarth, A J, Page, S P, Pepper, C B, Rhode, K, Lip, G Y H, Holden, A V, Plein, S & Tayebjee, M H 2017, ' Intra-cardiac and peripheral levels of biochemical markers of fibrosis in patients undergoing catheter ablation for atrial fibrillation ', Europace, vol. 19, no. 12, 315 . https://doi.org/10.1093/europace/euw315
Begg, G A, Karim, R, Oesterlein, T, Graham, L N, Hogarth, A J, Page, S P, Pepper, C B, Rhode, K, Lip, G Y H, Holden, A V, Plein, S & Tayebjee, M H 2017, ' Intra-cardiac and peripheral levels of biochemical markers of fibrosis in patients undergoing catheter ablation for atrial fibrillation ', EUROPACE, vol. 19, no. 12, pp. 1944–1950 . https://doi.org/10.1093/europace/euw315
Begg, G A, Karim, R, Oesterlein, T, Graham, L N, Hogarth, A J, Page, S P, Pepper, C B, Rhode, K, Lip, G Y H, Holden, A V, Plein, S & Tayebjee, M H 2017, ' Intra-cardiac and peripheral levels of biochemical markers of fibrosis in patients undergoing catheter ablation for atrial fibrillation ', EUROPACE, vol. 19, no. 12, pp. 1944–1950 . https://doi.org/10.1093/europace/euw315
Aims: Measurement of circulating biomarkers of fibrosis may have a role in selecting patients and treatment strategy for catheter ablation. Pro-collagen type III N-terminal pro-peptide (PIIINP), C-telopeptide of type I collagen (ICTP), fibroblast gro
Autor:
Harry B. Rossiter, Gordon A. Begg, T. Scott Bowen, Vivek Baliga, Klaus K. Witte, Daniel T. Cannon
Publikováno v:
Journal of applied physiology (Bethesda, Md. : 1985). 113(3)
Cardiopulmonary exercise testing for peak oxygen uptake (V̇o2peak) can evaluate prognosis in chronic heart failure (CHF) patients, with the peak respiratory exchange ratio (RERpeak) commonly used to confirm maximal effort and maximal oxygen uptake (
Publikováno v:
Circulation: Heart Failure. 3
To the Editor: We read with interest the study by Witham et al,1 suggesting that vitamin D supplementation does not improve quality of life or physical functioning in older patients with chronic heart failure (CHF). The authors are to be congratulate
Closing the Door After the Horse has Bolted: Device Therapy in Patients With End-Stage Heart Failure
Autor:
Klaus K. Witte, Gordon A. Begg
Publikováno v:
Journal of Cardiac Failure. 16:938-939
The management of patients with severe chronic heart failure (CHF) because of left ventricular systolic dysfunction (LVSD) has been transformed by device therapy over the past decade. In patients with New York Heart Association Class III and IV sympt